Westchester Capital Management (New York)’s The Oncology Institute TOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-548,090
Closed -$5.45M 408
2021
Q3
$5.45M Buy
548,090
+9,325
+2% +$92.6K 0.16% 89
2021
Q2
$5.36M Sell
538,765
-9,272
-2% -$93.3K 0.12% 82
2021
Q1
$5.46M Buy
548,037
+276,737
+102% +$2.95M 0.15% 88
2020
Q4
$2.93M Buy
+271,300
New +$2.79M 0.1% 105

Other funds holding TOI

Westchester Capital Management (New York)'s TOI Position: Q4 2021 in Review

Westchester Capital Management (New York) sold out of The Oncology Institute (TOI) in Q4 2021, closing a stake of 548,090 shares — an estimated $5.45M sold.

Westchester Capital Management (New York) first reported a position in TOI in Q4 2020 and held it in 4 quarters. The position peaked at $5.46M in Q1 2021. 21 funds tracked by Wall St. Rank hold TOI as of Q4 2021.

  • Westchester Capital Management (New York) reported no remaining The Oncology Institute position as of Q4 2021 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 548,090 The Oncology Institute shares in Q4 2021, an estimated $5.45M.
  • Westchester Capital Management (New York) first reported a position in The Oncology Institute in Q4 2020 and held it in 4 quarters.
  • Westchester Capital Management (New York)'s The Oncology Institute position peaked at $5.46M in Q1 2021.
  • 21 funds tracked by Wall St. Rank held The Oncology Institute as of Q4 2021.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2021, filed 14 Feb 2022.